PEDSEEK was developed with support from the ACCP to evaluate the effectiveness of a multimedia-based board review tool. Pediatric pulmonologists confirmed its need and supported its development, as presented previously. The CD was released in 2008 and its efficacy was evaluated.
This is a prospective, blinded, randomized case-control study occurring between June, 2007 and January, 2009. Surveys were conducted using SurveyMonkey with participants throughout the United States (N=60). The 200-question tool was created using cases, powerpoint presentations, and multimedia demonstrating bronchoscopic videos, sleep studies, pathology and radiology. A pre-test and post-test were created evaluating a preliminary version of the CD. Following the 2008 pediatric pulmonary board examination, participants were surveyed regarding the utility and effectiveness of PEDSEEK. This was confirmed three months after the board examination based on board scores.
Participants in the study improved on simulated tests following use of the preliminary version of PEDSEEK. Following the licensing examination in pediatric pulmonary, the large majority of respondents found PEDSEEK to be useful (91%), helpful (97%), interesting (84%) and educational (95%). The radiology, pathology, internet links and cases helped participants prepare for the examination. All participants recommended it be continued, and the large majority thought it would be useful for general education (88%), CME (94%) and recertification (94%). Following receipt of board scores, 88% of participants reconfirmed its usefulness.
PEDSEEK is an effective board review tool for pediatric pulmonologists and its continued development was unanimously endorsed.
Tools that incorporate cases, questions and multi-media are effective strategies for advancing medical education. These learner-centered strategies are likely beneficial across multiple medical disciplines and were perceived to benefit physicians-in-training and those with more experience.
Jonathan Puchalski, No Financial Disclosure Information; No Product/Research Disclosure Information